EDAP TMS Announces Upcoming General Meeting to Discuss Key Financial and Governance Matters

EDAP TMS ( (EDAP) ) has issued an update.

On June 27, 2025, EDAP TMS S.A. will hold an Ordinary and Extraordinary General Meeting at its headquarters in Vaulx-en-Velin, France. The agenda includes the approval of financial statements for the fiscal year 2024, ratification of board appointments, and several delegations of authority to the Board of Directors to increase share capital through various means. This meeting is significant as it will address key financial and governance issues that could impact the company’s strategic direction and shareholder value.

The most recent analyst rating on (EDAP) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on EDAP TMS stock, see the EDAP Stock Forecast page.

Spark’s Take on EDAP Stock

According to Spark, TipRanks’ AI Analyst, EDAP is a Neutral.

EDAP TMS’s overall stock score reflects financial challenges, including negative profitability and cash flow issues, despite promising strategic developments in the HIFU business. Technical analysis and valuation further underscore the caution, as the stock faces bearish sentiment and high risk. The earnings call highlights mixed sentiment, balancing innovation with financial strain.

To see Spark’s full report on EDAP stock, click here.

More about EDAP TMS

EDAP TMS S.A. is a company based in Vaulx-en-Velin, France, with a share capital of 4,896,010.47 euros. It operates within the medical technology industry, focusing on the development, production, and marketing of minimally invasive medical devices, particularly in the field of urology.

Average Trading Volume: 127,976

Technical Sentiment Signal: Sell

Current Market Cap: $66.56M

For a thorough assessment of EDAP stock, go to TipRanks’ Stock Analysis page.